The number of people taking funded dulaglutide (Trulicity) has doubled in New Zealand over the past two years and the diabetes medicine is in short supply again, along with its alternative, Victoza (liraglutide). Natasha Jojoa Burling reports
The number of people taking funded dulaglutide (Trulicity) has doubled in New Zealand over the past two years and the diabetes medicine is in short supply again, along with its alternative, Victoza (liraglutide). Natasha Jojoa Burling reports
PHARMACISTS CAN NOW ONLY dispense dulaglutide (Trulicity) once monthly because of global supply issues, and some think Pharmac should have acted sooner to head off the supply issue.
Pharmacists can only dispense dulaglutide (Trulicity) once monthly from today because of global supply issues, and some think Pharmac should have acted sooner to head off the supply issue
WellSouth Primary Health Network has created two new pharmacist roles aimed at improving health outcomes for Māori and Pacific communities in Otago and Southland.
A global supply shortage of GLP-1 agonist drugs - expected to last until next year - has seen manufacturer Lilly ask New Zealand health care providers to consider not prescribing Trulicity to new patients
Diabetes is the country's biggest and fastest-growing health condition and south Auckland is the region most affected. Ministry of Health figures show in 2020 there were 277,803 people with diabetes, with 47,988 in Counties Manukau alone